Capital Stage nanotech fund misses target

Zurich-based Capital Stage (Schweiz) AG, a 70% subsidiary of Hamburg-based Capital Stage AG has ceased its operations and will be liquidated. The company initiated its fund Capital Stage Nanotech Invest in spring 2002. The closure comes despite positive feedback from strategic partners as the fund manager could not win over a large enough number of investors in order to reach the target of EUR 100m. The fund manager was looking to sign institutional investors that were able to investment in excess of EUR 1m. Capital Stage does not anticipate a forthcoming change in the fundraising environment.

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• DACH